A mouse model for the study of vascular permeability changes induced by arsenic

Toxicology Mechanisms and Methods

Volumn 15, Issue 6, 2005, Pages 433-437

  Tsai, Ming Hsien ^a   Chen, Shih Chieh ^b   Wang, Hsiu Jen ^a   Yu, Hsin Su ^c   Chang, Louis W ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Arsenic Toxicity; Vascular Permeability

Indexed keywords

ARSENIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARSENIC POISONING; ARTICLE; BLOOD VESSEL PERMEABILITY; CELL CULTURE; CLINICAL RESEARCH; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EAR; ENDOLEAK; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; VASCULAR DISEASE;

ANIMALIA;

EID: 30744468583     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.1080/15376520500195640     Document Type: Article

References (22)

1. Abernathy, C. O., Calderon, R. L., and Chappell, W. R. 1997. Arsenic: Exposure and Health Effects. London: Kluwer Academic publisher.
2. Barchowsky, A., Dudek, E. J., Treadwell, M. D., and Wetterhahn, K. E. 1996. Arsenic induces oxidant stress and NF-κB activation in cultured aortic endothelial cells. Free Radical Biol. Med. 21:783-790.
3. Bates, M. N., Smith, A. H., and Hopenhayn, R. C. 1992. Arsenic ingestion and internal cancers: A review. Am. J. Epidemiol. 135:462-176.
4. Chappell, W. R., Abernathy, C. O., and Calderon, R. L. 1999. International Conference on Arsenic Exposure and Health Effects Staff, Arsenic Exposure and Health Effects. US: Elsevier.
5. Chappell, W. R., Beck, B. D, Brown, K. G., Chaney, R., Cothern, C. R., Irgo, K. J., North, D. W., Thornton, I., and Tsongas, T. A. 1997. Inorganic arsenic: A need and an opportunity to improve risk assessment. Environ. Health Perspect. 105:1060-1067.
6. Chen, C. J., and Wang, C. J. 1990. Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res. 50:5470-5474.
7. Chen, C. J., Chen, C. W., Wu, M. M., and Kuo, T. L. 1992. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic level in drinking water. Brit. J. Cancer 66:888-892.
8. Chen, C. J., Cuiou, H. Y., Chiang, M. H., Lin, L. J., and Tai, T. Y. 1996. Dose-mortality and long-term arsenic exposure. Arterioscler. Thromb. Vasc. Biol. 16:504-510.
9. Chen, C. J., Wu, M. M., Lee, S. S., Wang, J. D., Cheng, S. H., and Wu, H. Y. 1998. Atherogenicity and carcinogenicity of high-arsenic artesian well water. Multiple risk factors and related malignant neoplasms of blackfoot disease. Arterioscleriosis 8:452-460.
10. Chen, S. C., Tsai, M. S., Wang, H. J., Yu, H. S., and Chang, L. W. 2004. Vascular permeability alternations induced by arsenic. Hum. Exp. Toxicol. 23:1-7.
11. Chiou, H. Y., Hsueh, Y. M., Liaw, K. F., Horng, S. F., Chiang, M. H., Pu, Y. S., Lin, J. S., Huang, C. H., and Chen, C. J. 1995. Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan. Cancer Res. 55:1296-1300.
12. Eriksson, E., Boykin, J. V., and Pittman, R. N. 1980. Method for in vivo microscopy for the cutaneous microcirculation of the hairless mouse ear. Microvas. Res. 19:374-379.
13. Hutchinson, J. 1987. Arsenic and cancer. Brit. Med. J. 2:1280-1281.
14. Hutchinson, J. 1988. Diseases of the skin: I. On some examples of arsenic-keratosis of the skin and of arsenic-cancer. Trans. Pathoogyl. Soc. Lond. 39:352-363.
15. Kao, Y. H., Yu, C. L., Chang, L. W., and Yu, H. S. 2003. Low concentrations of arsenic induces vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vivo. Chem. Res. Toxicol. 16:460-468.
16. Liu, F., and Jan, K. Y. 2000. DNA damage in arsenite and cadmium-treated bovine aortic endothelial cells. Free Rad. Biol. Med. 28:55-63.
17. Tseng, W. P. 1977. Effects and dose-response relationship of skin cancer and blackfoot disease with arsenic. Environ. Health Perspect. 19:109-119.
18. Tsou, T. C., Tsai, F. Y., Wu, M. C., and Chang, L. W. 2003. The protective role of NF-B and AP-1 in arsenite-induced apoptosis in aortic endothelial cells. Toxicol. Appl. Pharmacol. 191:177-187.
19. Wang, S. L., Chiou, J. M., Chen, C. J., Tseng, C. H., Chou, W. L., Wu, T. N., and Chang, W. L. 2003. Prevalence of non-insulin dependent diabetes mellitus and related vascular diseases in Southwestern arseniasis-endemic and non-endemic areas in Taiwan. Environ. Health Perspect. 111:155-160.
20. Wu, M. M., Kuo. T. L., Hwang Y. H., and Chen, C. J. 1989. Dose-response relatility from cancers and vascular diseases. Am. J. Epidemiol. 130:1123-1132.
21. Yeh, J. Y., Cheng, L. C., Ou, B. R., Whanger, D. P., and Chang, L. W. 2002. Differential influences of various arsenic compounds on glutathione redox status and antioxidative enzymes in porcine endothelial cells. Cell. Mol. Life Sci. 59:1972-1982.
22. Yu, H. S., Shen, H. M., Ko, S. S., Chiang, L. C., Chien, C. H., Lin, S. M., Tserng, B. R., and Chen, C. S. 1984. Studies on Blackfoot disease and chronic arsenism in southern Taiwan: With special reference to skin lesions and fluorescent substances. J. Dermatol. 11:361-370.